US Patent Issued to The Trustees of the University of Pennsylvania on July 14 for "Treatment of cancer with CDK inhibitors" (Pennsylvania Inventor)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,438, issued on July 14, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"Treatment of cancer with CDK inhibitors" was invented by Irfan Asangani (Wallingford, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating cancer by administration of a cyclin dependent kinase (CDK) inhibitor to a subject."

The patent was filed on April 24, 2020, under Application No. 17/605,971.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1...